$CLSH News: CLS Holdings USA, Inc. Announces Second Quarter

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
138
$CLSH News: CLS Holdings USA, Inc. Announces Second Quarter Fiscal 2021 Results

LAS VEGAS, NV / ACCESSWIRE / January 13, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH), (CSE:CLSH) ("CLS" or the ‘‘Company'' , a diversified cannabis company operating as Cannabis Life Sciences, today announced its operational and financial results for the second quarter of fiscal 2021, ended November 30, 2020. The Company experienced its highest revenue month in this period, setting historic company records for revenue and gross margin. Despite anticipated seasonal slow-down and continued depressed tourism in Nevada, CLS entities in the state maintained high sales volumes with aggressive promotions that effectively served the local community in an economically challenged market.

Key Q2 Financial Accomplishments

Total revenues were $4,907,889 compared to $3,056,431 reported in the same quarter in 2019, representing an increase of over 61%, and a 29.8% increase over the first fiscal quarter of 2021.
Gross margin increased to 55% - an increase of 7% over the quarter ended November 30, 2019.
CLS manufacturing division, City Trees, achieved a 58% increase in year-over-year quarterly revenue through a successful rebrand, a newly curated product catalog, and reinvigorated sales efforts.
Retail division, Oasis Cannabis, continued to see significant in-store, delivery, and curbside traffic that drove a 22.1% increase in the average daily revenue total and a 7.6% year-over-year increase in the total number of customers served.
The average transaction total at Oasis Cannabis rose 13.4% year-over-year, from $49.39 in the second quarter of fiscal 2020 to $56.02 in the comparable quarter of fiscal 2021.
Operational Highlights



CLS entities in Nevada saw remarkable progress across all verticals in the second quarter, starting at the beginning of September with the successful rebrand of its branded product division, City Trees. Converting its packaging to more sustainable materials and refocusing its efforts on producing high quality concentrates and other accessibly priced extraction products, the brand is progressively becoming a mainstay name in the Nevada cannabis market. Through the combined effect of its rebranding efforts, increased product assortment, and reinvigorated sales efforts, this division achieved a 58% increase year-over-year quarterly revenue. This improvement was further impacted by the release of City Trees' new website, which provides indirect e-commerce opportunities and more in-depth informational content, including material surrounding its sustainability initiatives. With its Buy 1 Plant 1 campaign, City Trees contributed, alongside 19 other companies, in planting over 115,000 trees in 2020.



City Trees also released a limited edition collaboration product with regional cultivator, State Flower, in November. This concentrate product represented the first co-branded product produced by this division as the brand continues to build notoriety as a craft concentrate producer in Nevada. The first batch of this limited run product sold out at the Company's storefront, Oasis Cannabis, in one week. Further, City Trees also produced the highest selling tincture product in the state of Nevada in 2020, a trend that continued through the second fiscal quarter of 2021.

CLS retail operation, Oasis Cannabis Dispensary, saw its highest revenue month to date in this quarter, achieving over $1.4 million in net revenue in October 2020. Total CLS revenue for October reached over $1.78 million - a 74.2% increase over October 2019. In September, Oasis unveiled its new wall of on-site billboards, presenting a uniquely targeted opportunity for advertising material for CLS subsidiaries and third party vendor partners. In this quarter, Oasis Cannabis also saw a 13.4% increase in the average dollar amount per transaction. While this division is still operating with significantly reduced in-store capacity and fewer daily operating hours, delivery and curbside services helped maintain a steady flow of orders through the dispensary. Oasis served an average of 732 customers per day in this quarter, up from an average of 680 customers per day for the same period in 2019. In this quarter, Oasis also achieved its highest single day revenue total, its highest revenue month, and a company record for Black Friday sales.



"We have a lot to be proud of from this last quarter. Beyond the revenue records that were yet again broken, and beyond the amazing research and development happening in our lab, we were most proud of our team that continues to serve Las Vegas through these challenging months" said Company President and COO, Andrew Glashow. "We have many exciting partnership opportunities and even more room to grow in 2021."

In addition to the improvements at the retail and brand level, CLS unveiled a new corporate website in the second quarter, adding its third new digital asset in the last 12 months. As the Company strengthens its foothold in retail and manufacturing, outpacing state-wide market growth in consecutive months in 2020, it has also focused on its position as a thought leader in the cannabis industry. With its participation in the 2020 Canaccord Genuity Virtual Cannabis Symposium and the Growth from Home speaker series, CLS has continued to spread its message of sustainability and strategic expansion across the industry.





About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. https://www.clsholdingsinc.com/

Twitter: @CLSHoldingsUSA



Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named "Best Dispensary for Pot Pros" by Desert Companion Magazine. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products. http://oasiscannabis.com.





Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada. https://citytrees.com



Forward Looking Statements

This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements'' . These statements relate to, among other things, the impact of the COVID-19 virus on our business, the results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the effect of our initiatives to expand market share and achieve growth during and following the pandemic, results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material. In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.

Contact Information:

Corporate:
Chairman and CEO
Jeff Binder

President and COO
Andrew Glashow
888-438-9132

Investor Relations:
investors@clsholdingsinc.com

SOURCE: CLS Holdings USA, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 393

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 220

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 298

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 110

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 150

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 188

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 331

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 318

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 361

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 227

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading

Top 5 Most Recently Viewed Articles

Carrier's $2.5 Million Commitment for Wildfire Relief Efforts

Updated Category News Views 244

Carrier's Generous Pledge for Wildfire Relief In a significant initiative aimed at supporting communities affected by wildfires, Carrier Global Corporation (NYSE: CARR), a leader in intelligent climate solutions, has announced its commitment to donate over $2.5 million worth of indoor air purifiers. This effort is specifically directed towards enhancing air quality for...

Continue Reading
Lundbeck Unveils New Insights on Multiple System Atrophy

Updated Category News Views 358

Lundbeck Reveals Insights into Multiple System Atrophy at International Congress VALBY, Denmark – H. Lundbeck A/S (Lundbeck) is set to present pivotal pipeline data and invaluable patient perspectives from the recent AMULET trial, highlighting amlenetug as a promising treatment for the rare neurological disorder known as multiple system atrophy (MSA). This significant...

Continue Reading
Keenova Therapeutics: A New Era for Mallinckrodt's Spin-Off

Updated Category News Views 599

Welcome to Keenova Therapeutics In an exciting announcement, Mallinckrodt plc has successfully completed the planned spin-off of its Par Health generic pharmaceuticals and sterile injectables businesses. As of now, the company will operate under the new name, Keenova Therapeutics, dedicating its efforts towards developing and delivering innovative therapies for patients...

Continue Reading
BlackRock, Inc. Increases Shareholding in Ageas to 7.78%

Updated Category News Views 154

Recent Financial Developments at Ageas In an important disclosure regarding financial transparency, BlackRock, Inc. has officially notified Ageas that it has exceeded the legal threshold of 5% ownership in the company, with its current shareholding reaching an impressive 7.78%. This notification was made in accordance with regulatory requirements aimed at maintaining...

Continue Reading
AKWEL Reports Revenue Decline in Nine-Month Financial Update

Updated Category News Views 48

Decline in Revenue for AKWEL in Recent Financial Update AKWEL, a key player in the automotive and heavy-vehicle parts market, has announced a notable decline in their financial performance for the first nine months of the year. The company, specializing in fluid management and structural parts for electric vehicles, has reported a consolidated revenue of €757.7 million,...

Continue Reading